Clinical Trials
8 trialsNCT06881992 2026-05-18
Tumor HI
Rezolute
Phase 3 Recruiting
NCT01916148 2026-04-27
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Children's Hospital of Philadelphia
Available
NCT05088798 2025-12-19
18FDOPA HI
Washington University School of Medicine
Phase 2 Recruiting
NCT07262970 2025-12-04
Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor
Rezolute
Available
NCT02021604 2024-07-16
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Cook Children's Health Care System
Phase 1 Recruiting
NCT04452396 2023-12-12
CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia
Barts & The London NHS Trust
Phase NA Terminated
NCT02779257 2022-03-04
Pasireotide Treatment for Neuroendocrine Tumor
University of Maryland, Baltimore
Phase 4 Withdrawn
NCT00937079 2015-01-09
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
University Hospital, Basel, Switzerland
Completed